• Icahn Slams Forest Laboratories, Inc. (FRX) Over FDA Warning Letter More...

• Onconova Therapeutics Inc. Logs $50 Million More...

• Kineta Inc. Pulls in $5.8 Million for Autoimmune Drug More...

• Upsher-Smith Laboratories Completes Acquisition of Proximagen Group plc. More...

• Cortex Pharmaceuticals, Inc. (COR) and Pier Pharmaceuticals Consummate Merger More...

• IMS Health (RX) Expands Suite of Syndicated, Web-based Analytics With Acquisition of PharmaDeals Ltd. More...

• Pfizer Inc. (PFE) to Pay $250 Million to AstraZeneca PLC (AZN) for OTC Nexium Marketing Rights More...

• Arrowhead Research Corporation (ARWR) Enters Into Antibody Candidate Evaluation Agreement With Merck & Co., Inc. (MRK) More...

• Plasticell and EMD Millipore Complete Licensing Deal to Distribute Fully Defined, Xeno-Free Mesenchymal Stem Cell Differentiation Media More...

• Bioniche Life Sciences Inc. (BNC) Enters Into an Exclusive U.S. Distribution Agreement for an Equine Product More...

• Zenobia Therapeutics, Inc. Announce a Partnership With the Alzheimer's Drug Discovery Foundation More...

• Dynavax Technologies Corporation (DVAX) AppointsChristine Larson as Chief Financial Officer More...

• ADVENTRX Pharmaceuticals Inc. (ANX) Announces Appointment of Chief Medical Officer More...

• Pharmacyclics, Inc. (PCYC) Appoints Joshua T. BrummExecutive Vice President of Finance More...

• Patheon Inc. (PTI.TO) Announces a Change to Its PDS Management Structure More...

• Array BioPharma, Inc. (ARRY) Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 More...

• Athersys, Inc. Reports Second Quarter 2012 Results More...

• Bioanalytical Systems, Inc. (BASI) Returns to Profitability Before Restructuring Charges for The Third Quarter Of Fiscal 2012 More...

• Celsion Corporation (CLN) Reports Second Quarter 2012 Financial Results and Business Update More...

• Derma Sciences, Inc. (DSCI) Reports Second Quarter 2012 Financial Results More...

• Shire plc (SHPG) May Leave Wayne to Brace for Potential Expansion More...

• Morphotek Inc. Opening Factory in Exton More...

• FDA Approves New Flu Vaccine for Upcoming Season More...

• Aegerion Pharmaceuticals, Inc. Scores a Date With the FDA More...

• Santarus Inc. (SNTS) Announces FDA Extension of UCERIS New Drug Application Target Action Date to January 16, 2013 More...

• Hemispherx Biopharma (HEB) Release: FDA Accepts Complete Response Submission Regarding the Ampligen® New Drug Application for Chronic Fatigue Syndrome More...

• Biovest International, Inc. Conducts End of Phase III Review With FDA of BiovaxID™ as Consolidation Therapy in Non-Hodgkin's Lymphoma More...

• Spectrum Pharmaceuticals, Inc. (SPPI) Commences Patient Enrollment in Randomized Phase 2b Clinical Trial of Ozarelix for Hormone-Dependent Prostate Cancer More...

• Coronado Biosciences Initiates Phase 2 Clinical Trial of TSO for the Treatment of Crohn's Disease More...

• Synergy Pharmaceuticals Completes Screening and Planned Enrollment in Phase IIb/III Study in Chronic Idiopathic Constipation Patients More...

• Proteonomix, Inc. (PROT) Receives FDA Permission to Initiate Company-Sponsored Phase 1 Clinical Trial With UMK-121 in Patients with End-Stage Liver Disease More...

• Egg Yolks as Bad as Smoking for Heart, London Health Sciences Centre's University Hospital Study More...

• Snoring in Toddlers Could be Sign of Behavioral Problems, Cincinnati Children's Hospital Medical Center Study More...

• Elderly Brains Get a Boost From Dark Chocolate, University of L'Aquila Study More...

• Why Are People Overconfident So Often? University of Navarra Study More...

• TONIX Pharmaceuticals, Inc. Reports That Sublingual Formulation of Fibromyalgia Drug Reduces Production of a Psychoactive Metabolite, Improving Suitability for Long-Term, Chronic Treatment More...

• OncoNatural Solutions Release: Over-the-Counter Prostate Treatment PHC&#0174 Awarded U.S. Patent More...

• Aptalis Pharmaceutical Technologies Announces U.S. Commercial Availability of VIOKACE™ (Pancrelipase) Tablets More...